The Pharmacovigilance Risk
Assessment Committee (PRAC)
has started a review of nasal
and mouth sprays containing the
antibiotic fusafungine, used to treat
infections of the upper airways.
The review will encompass
the benefits and risks of these
medicines and issue an opinion
on their marketing authorisations
across the European Union, the
European Medicines Agency said.
For highlights from the PRAC 07-
10 Sep meeting and more on the
fusafungine review,The above article was sent to subscribers in Pharmacy Daily's issue from 16 Sep 15 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 16 Sep 15
THE role and significance of community pharmacy in regional areas was a key focus of discussion for the Nationals leader David Littleproud during last week’s visit to Orana Mall Pharmacy as part of a regional tour.
MEDICATION management platform MedAdvisor Limited (MDR) showed strong financial performance for the quarter concluded on 31 Mar 2024, with operating revenue up 42% to $24.2 million from $17 million for the same period last year.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.